Licarbazepine clinical trials
How each study uses licarbazepine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Licarbazepine
- 8
Studies by the year they started
8 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Studies
Open first, then newest update. How each study uses licarbazepine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderCompletedPhase 4NovartisNCT00139594Written as licarbazepine
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I DisorderCompletedPhase 3NovartisNCT00238485Written as Licarbazepine
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedPhase 3Novartis PharmaceuticalsNCT00107926Written as Licarbazepine
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedPhase 3Novartis PharmaceuticalsNCT00107939Written as Licarbazepine
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedPhase 3Novartis PharmaceuticalsNCT00099229Written as Licarbazepine
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.CompletedPhase 3NovartisNCT00228059Written as Licarbazepine
- Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of LicarbazepineCompletedPhase 1NovartisNCT00426036Written as Licarbazepine
- Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of LicarbazepineCompletedPhase 1NovartisNCT00424671Written as Licarbazepine
Codes
What other systems call licarbazepine · ClinicalTrials.gg INT004351
- UNII (FDA) XFX1A5KJ3VLICARBAZEPINEConfirmed FDA, NLM, Wikidata
- Wikidata Q6542996licarbazepineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81475LicarbazepineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XFX1A5KJ3V | LICARBAZEPINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6542996 | licarbazepine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81475 | Licarbazepine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.